Cardiac Arrest (CA)
0
Pipeline Programs
3
Companies
3
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
Human BioSciencesOPTI-VENT Bundle
NeurescueAdvanced Cardiac Life Support
ZollDutch Registry of Pediatric Cardiac Arrest
Clinical Trials (3)
Total enrollment: 2,114 patients across 3 trials
Optimal Ventilation for Cardiac Arrest
Start: Oct 2025Est. completion: Mar 20301,530 patients
N/ARecruiting
A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support
Start: Jul 2025Est. completion: Mar 202784 patients
N/ARecruiting
Dutch Registry of Pediatric Cardiac Arrest
Start: Jun 2023Est. completion: Jan 2030500 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials targeting 2,114 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.